ALLMedicine™ Gastric Cancer Center
Research & Reviews 16,349 results
https://doi.org/10.1007/s00262-022-03240-2 10.1016/j.immuni.2016.04.023 10.1038/nrc.2016.36 10.1158/1078-0432.Ccr-13-3271 10.1056/NEJMoa1200690 10.1016/s0140-6736(17)31827-5 10.1073/pnas.1705327114 10.1158/1078-0432.Ccr-18-1449 10.1007/s00262-018-2225-x 10.3389/fimmu.2018.00014 10.4049/jimmunol.178.7.4112 10.1084/jem.186.9.1407 10.1084/jem.20030235 10.1002/eji.200525983 10.1002/cyto.a.20643 10.1016/j.bbrc.2016.08.115 10.1093/jjco/hyaa202 10.1001/jamaoncol.2018.0013 10.1016/s0140-6736(18)31257-1 10.1001/jamaoncol.2020.3370 10.1007/s10120-016-0631-3 10.1016/s1470-2045(20)30169-8 10.1038/nri.2015.3 10.1158/0008-5472.Can-15-1545 10.1038/s41416-020-0813-y 10.1186/s40425-018-0399-6 10.1158/1078-0432.Ccr-13-1877 10.4049/jimmunol.1402711 10.1016/j.cellimm.2018.02.002 10.1158/1078-0432.Ccr-17-2257 10.1016/j.ctrv.2016.11.007 10.1126/science.aaa1348 10.1056/NEJMoa1406498 10.1038/s41467-018-05072-0 10.1158/1078-0432.Ccr-13-0945 10.1002/ijc.26297 10.1158/2326-6066.Cir-14-0239 10.1186/s13059-019-1921-y 10.1038/nm.4051 10.1080/25785826.2019.1698261 10.1158/2326-6066.Cir-15-0210 10.1093/intimm/dxx073 10.1038/s41586-021-03752-4
Cancer Immunology, Immunotherapy : CII; Nose Y, Saito T et. al.
Jul 2nd, 2022 - Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. Since clinical benefits are limited to a subset of patients, we aimed to identify peripheral blood biomarkers that predict the efficacy of the anti-programmed cell death pro...
https://doi.org/10.1111/jhn.13057
Journal of Human Nutrition and Dietetics : the Official J... Burden ST, Bibby N et. al.
Jul 2nd, 2022 - Cancer patients are often malnourished pre-operatively. Study aims were to establish if current screening was appropriate for use in prehabilitation and investigate any association between nutritional risk, functionality and quality of life (QoL)....
https://doi.org/10.1111/liv.15355
Liver International : Official Journal of the Internation... Gu D, Zhang M et. al.
Jul 2nd, 2022 - Prior studies suggested that patients with autoimmune liver diseases (AiLD) had an increased risk of cancer, wheras the causal effect remained unclear. Meta-analyses concerning the relationship between AiLD and cancer risk were performed to calcul...
https://doi.org/10.1007/s00432-022-04124-9 10.1007/s11306-011-0297-0 10.1038/s41571-020-0382-2 10.1136/gutjnl-2019-320234 10.1126/science.aad5168 10.3892/or.2011.1378 10.3748/wjg.v16.i46.5874 10.1038/nrc3340 10.1038/s41586-019-1150-2 10.1158/0008-5472.CAN-12-1600 10.1098/rsfs.2012.0101 10.1016/j.imlet.2018.03.007 10.1038/nrendo.2015.117 10.1093/bfgp/ely006 10.1002/cncr.33050 10.1158/0008-5472.CAN-08-4806 10.3748/wjg.v17.i6.727 10.1038/s42255-019-0161-5 10.1016/j.phrs.2016.10.027 10.1038/s41571-019-0203-7 10.1016/j.tibs.2015.12.001 10.3748/wjg.v19.i12.1912 10.1016/j.cmet.2020.10.021 10.1038/nmeth.4575 10.1038/414916a 10.1073/pnas.0605251103 10.3892/or.2011.1302 10.1590/S0100-879X2011007500158 10.3322/caac.21660 10.1038/s41591-021-01233-9 10.1126/science.aao2774 10.1016/j.celrep.2021.109516 10.3892/ijo.2017.4000 10.1016/j.stem.2018.09.016 10.1126/science.abe6474
Journal of Cancer Research and Clinical Oncology; Liu HY, Wang FH et. al.
Jul 2nd, 2022 - Nicotinamide adenine dinucleotide (NAD+) is closely related to the pathogenesis of tumors. However, the effect of NAD+ metabolism of gastric cancer (GC) cells on immune cells remains unexplained. We targeted nicotinamide phosphoribosyltransferase ...
https://doi.org/10.1097/MD.0000000000029798
Medicine Li D, Li W et. al.
Jul 2nd, 2022 - Lymphovascular invasion is considered to be a high-risk pathological feature after radical resection of gastric cancer, but the relationship between lymphovascular invasion and the prognosis of stage I gastric cancer is still controversial. Theref...
Guidelines 23 results
https://doi.org/10.6004/jnccn.2022.0008
Journal of the National Comprehensive Cancer Network : JN... Ajani JA, D'Amico TA et. al.
Feb 8th, 2022 - Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor p...
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.
Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...
https://doi.org/10.6004/jnccn.2021.0001
Journal of the National Comprehensive Cancer Network : JN... Daly MB, Pal T et. al.
Jan 7th, 2021 - The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116190
The Lancet. Oncology; Blair VR, McLeod M et. al.
Aug 8th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;
Nov 26th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...
Drugs 4 results see all →
Clinicaltrials.gov 1,710 results
https://clinicaltrials.gov/ct2/show/NCT03472365
Jul 1st, 2022 - Approximately 110 participants will be assigned to SHR-1210 + capecitabine + oxaliplatin combination therapy (Cohort 1), or SHR-1210 + apatinib combination therapy (Cohort 2).
https://clinicaltrials.gov/ct2/show/NCT04535414
Jul 1st, 2022 - Background: Hereditary Diffuse Gastric Cancer (HDGC) is most often attributed to inactivating germline mutations in the E-cadherin (CDH1) tumor suppressor gene. Mutation carriers have a 24-70% lifetime risk of developing gastric adenocarcinoma. In...
https://clinicaltrials.gov/ct2/show/NCT00450788
Jul 1st, 2022 - Esophageal cancer is the sixth most common cause of cancer death worldwide, killing over 380,000 people each year. Over 80% of esophageal cancers occur in developing countries, where the great majority of cases are squamous cell carcinomas. Esopha...
https://clinicaltrials.gov/ct2/show/NCT01468922
Jul 1st, 2022 - Background: Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) signal transduction pathways have synergistic effects on promoting angiogenesis and growth factor expression. Hypoxia caused by treatment with VEGF inhibitors...
https://clinicaltrials.gov/ct2/show/NCT03030404
Jul 1st, 2022 - Background: An estimated 1-3% of gastric cancer cases occur within a familial background as part of an inherited cancer syndrome. Hereditary Diffuse Gastric Cancer (HDGC) is the most frequent form of familial gastric cancer and has been linked to ...
News 775 results
https://www.mdedge.com/hematology-oncology/article/255995/gastrointestinal-cancer/commentary-ramucimumab-napabucasin-and
Nataliya Uboha, MD, PhD
Jul 1st, 2022 - Patients with advanced gastroesophageal adenocarcinoma (GEA) have a poor prognosis. Despite recent improvements in treatments, overall survival (OS) for most of these patients remains < 18 months.
https://www.mdedge.com/hematology-oncology/article/255641/gastrointestinal-cancer/artificial-intelligence-may-support
Jun 22nd, 2022 - Key clinical point: Artificial intelligence (AI) shows high sensitivity, specificity, and accuracy for the diagnosis of early gastric cancer. Major finding: The pooled sensitivity and specificity of AI for early gastric cancer diagnosis were 0.
https://www.mdedge.com/hematology-oncology/article/255639/gastrointestinal-cancer/nonmetastatic-gastric-cancer-survival
Jun 22nd, 2022 - Key clinical point: There is no improvement in survival of patients with nonmetastatic gastric adenocarcinoma in selected European countries. The survival has slightly improved in the US and worsened in Sweden.
https://www.mdedge.com/hematology-oncology/article/255638/gastrointestinal-cancer/laparoscopic-gastrectomy-safe-elderly
Jun 22nd, 2022 - Takeaway: Laparoscopic vs. open gastrectomy (LG vs.
https://www.mdedge.com/hematology-oncology/article/255637/gastrointestinal-cancer/gastric-cancer-epstein-barr-virus-and-h
Jun 22nd, 2022 - Key clinical point: Epstein-Barr virus (EBV) and Helicobacter pylori coinfection is not an independent prognostic factor for gastric cancer. EBV infection was associated with survival, but not in patients with non-gastric carcinoma with lymphoid s.